Capital Fund Management S.A. Denali Therapeutics Inc. Transaction History

Capital Fund Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$20.88 - $35.19 $280,689 - $473,059	-13,443 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$29.0 - $47.27 $10,440 - $17,017	-360 Reduced 2.61%	13,443 $432,000
Q4 2021 Feb 10, 2022	SELL	$42.59 - $55.02 $136,373 - $176,174	-3,202 Reduced 18.83%	13,803 $615,000
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $252,289 - $407,108	5,204 Added 44.1%	17,005 $857,000
Q2 2021 Aug 12, 2021	SELL	$50.3 - $78.44 $2.04 Million - $3.18 Million	-40,518 Reduced 77.44%	11,801 $925,000
Q1 2021 May 14, 2021	BUY	$53.8 - $81.53 $2.81 Million - $4.27 Million	52,319 New	52,319 $2.99 Million

228

120M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.21B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.